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probability depends on the accuracy of the alpha-beta ratio 
for prostate cancer, the value of which is still a matter of 
discussion in the scientific community. Therefore various 
scenarios should be investigated for understanding the limits 
of the biologically-based dose escalation to the tumour 
during prostate radiotherapy.  
 
Material and Methods: This work investigates the potential 
and limits of biologically-based treatment planning for ten 
prostate-cancer patients with localised disease in the case of 
alpha-beta-ratios of 1.5 Gy, 3 Gy, and 4.5 Gy, respectively. 
The MR images of these patients were used for contouring 
the intraprostatic lesion as GTV and were matched with the 
CT images in EclipseTM. Biologically-based 7-fields IMRT plans 
were optimised by minimising the NTCP for rectal bleeding 
and bladder contracture and by maximising the TCP for the 
GTV. For all patients, the dose prescription for the PTV 
(whole prostate) was 72 Gy in 40 fractions.  
 
Results: The results of this plan-comparison study show that 
the individual GTV dose coverage depends on the alpha-beta 
ratio for prostate cancer, while the calculated dose 
distribution (in particular the mean dose values and the D3%) 
for rectum and bladder are not influenced by this parameter. 
Also, the total dose to the GTV could be individually 
optimised and varied between 76 Gy and 87 Gy, depending on 
the position of the DIL within the prostate. Finally, the 
optimised total dose to the GTV increased when modelling 
the TCP with a lower alpha-beta ratio, with individual 
differences up to 3 Gy. 
 
Conclusion: Biologically-based optimisation tools allow for 
individualised dose escalation in dominant intraprostatic 
lesions and, in principle, could be safely used for the 
treatment planning of prostate cancer. In fact, a variation of 
the alpha-beta ratio for prostate cancer between 1.5 Gy and 
4.5 Gy causes a variation of the dose coverage of the GTV of 
up to about 3 Gy in total, thus showing an acceptable 
robustness of the TCP model with respect to this parameter. 
Biologically-based optimisation tools, finally, have the 
advantage of reducing optimisation time, contouring process, 
and dose hot spots. Studies are currently being carried out in 
order to further validate the TCP and NTCP models for 
prostate cancer treatment in the case of hypofractionated 
schedules. 
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Purpose or Objective: Accuracy of radiotherapy to the 
prostate is often challenged by geometrical uncertainties due 
to inherent organ motion attributed to daily variations of the 
bladder and rectal volumes and contents. This study aims to 
simulate the use of 4D Clarity ultrasound image guidance 
without CBCT imaging to analyse the magnitude and trend of 
prostate motion during treatment (74Gy given in 37 
fractions). The impact of CBCT imaging and verification time 
on prostate motion will be analysed. 
 
Material and Methods: 175 intra-fraction monitoring sessions 
from 5 patients who underwent radical prostate volumetric 
modulated arc therapy (VMAT) monitored using 4D 
transperineal ultrasound scan (TPUS) resulted in a total of 
1461.2min of data (184,085 positioning points) being 
analysed. All patients were instructed to comply with a full 
bladder protocol (i.e. 300-450ml in 30-45min) without 
specific rectal preparation protocol. Mean prostate motion 
was calculated and analysed in relation to time in the 
subsequent fractions. Overall treatment time was defined 
from acquisition of CBCT to treatment beam off time and 
imaging time was defined from time of CBCT acquisition to 
first beam on. Imaging time was subtracted from the overall 
treatment time for analysis of prostate motion without CBCT 
for verification. The remaining duration was representative 
of treatment time using 4D Clarity ultrasound image guidance 
alone. The impact of CBCT imaging and verification time on 
prostate motion was analysed. 
 
Results: Mean (median) imaging and overall treatment time 
was 4.6min (4.4 min) and 8.4min (8.3 min) respectively. 
Mean (median) prostate motion during overall treatment time 
was 0.7mm (0.6mm) Inf, 1.0mm (0.9mm) Post and 0.1mm 
(0.2mm) Lt respectively. Mean prostate motion without CBCT 
was 0.6mm (0.5mm) Inf, 0.9mm (0.8mm) Post and 0.1mm 
(0.1mm) Lt. Figure 1 demonstrates the observed prostate 
displacement over time in a single session from one of the 
patients. In general, the mean (median) maximum prostate 
drift during actual treatment alone tends to trend towards 
the following directions at 3.6mm (3.4mm) Inf, 7.4mm 
(5.2mm) Ant and 2.7mm (2.8mm) Lt. Magnitude of the 
median maximum prostate displacement increased relatively 
by 38.4%, 16.7% and 46.6% in the Inf, Ant and Lt directions 




Conclusion: Prolonged overall treatment time due to CBCT 
imaging and verification time increases the intra-fraction 
prostate motion. We propose the use of 4D Clarity TPUS in 
place of TPUS with CBCT to reduce imaging time before 
radiotherapy to reduced total verification time leading to 
reduced prostate movement. Consequently, the magnitude of 
intra-fraction prostate motion could be reduced from 
reduced image acquisition and reconstruction time. This 
reduces the total in room time per patient and maximises 
patient through-put and treatment efficiency which is 
important in a busy radiotherapy centre. 
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Purpose or Objective: To investigate the Geometric 
difference between six different ITVx delineation methods 
from 4D-CT  
for patients with Non Small Cell Lung Cancer (NSCLC) treated 
with Stereotactic Ablative Radiotherapy  
(SABR) technique. 
 
Material and Methods: Between December 2013 and March 
2014, 46 patients who underwent SABR were includedin  
this retrospective study. All patients underwent imaging 
acquisition with 4D-CT scans, The tu- 
mor motion range, volume , marching index (MI) and 
encompassment index (EI) of ITV10, IT- 
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VYeo, ITVEI+EE(End of Inspiration + End of Expiration), 
ITVODD (delineated from five odd p-hases), ITVEVEN 
(delineated from five even phases), ITVAVG (Average 
sequences) , and IT-VMIP (Maximum Intensity Projection 
sequences) were calculated and evaluated, finally, a me- 
thod , which was not sensitive to the tumor volume and 
motion characteristic was selected  
for clinical use. 
 
Results: The mean tumor motion (RLR, RAP, RCC, and R3D) 
were 
3.5mm(1.4mm~8.4mm)，4.5mm(1.1mm~8.6mm)，9.5mm(0m
m~10mm),12.3mm (2.5-55.3 mm) respectively. Compared 
with ITV10, the volume of ITVx were underestimated 
by25.7%、35.6%、17.9%、12.8%、3.6%、4.8% (P=0.000) 
respectively. MI comparisons between six ITVx delineation 
methods and ITV10 had statistical significance: 
0.69、0.62、0.80、0.86、0.93、0.91（P=0.006） EI showed 
no statistical significance: 
0.98、0.98、0.97、0.97、0.99、0.98（P=0.13）, the tumor 
volume and motion amplitude were certified not the 
independent factors for the MI of ITVODD and ITVEVEN. 
 
 Range Mean±SD Comparison P value 
RVI _ITVMIP 0.53-0.91 0.74±0.12 ITV10 - ITVMIP 0.00 
RVI _ITVAVG 0.36-0.88 0.64±0.13 ITV10 - ITVAVG 0.00 
RVI _ITVIE+EE 0.71-0.88 0.82±0.51 ITV10 - ITVIE+EE 0.00 
RVI _ITVyeo 0.75-0.95 0.87±0.06 ITV10 - ITVyeo 0.00 
RVI _ITVODD 0.88-0.98 0.97±0.02 ITV10 - ITVODD 0.53 
RVI _ITVEVEN 0.83-0.96 0.95±0.04 ITV10 - ITVEVEN 0.17 
 
Conclusion: ITVODD/EVEN was not sensitive to tumor size or 
motion characteristic and was proved to have a good 
marching with ITV10 meanwhile having a relative high 
contouring efficiency, it can be recommend as a  
universal ITV delineation method to the institutions which 
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Purpose or Objective: In recent years, 3DCRT and IMRT have 
been used frequently as a treatment approach for prostate 
cancer patients. In particular, there is a tendency that a 
short-term treatment is performed with the use of a high 
dose rate machine. For this reason, even a small movement 
of the intra-fraction prostate motion error is also important. 
In this study, we divided one time of irradiation of 3DCRT and 
IMRT into 2 stages, i.e., the early phase and the late phase, 
and examined the intra-fraction prostate motion errors in a 
single irradiation. 
 
Material and Methods: A total of 154 patients with prostate 
cancer were treated from January 2005 to December 2013. 
Three gold markers were inserted into their prostate gland 
before starting radiotherapy. Patients treated with 3DCRT 
(88 pts) were fixed at their lower limbs using HF-A (TOYO 
MEDIC) in the supine position, and those treated with IMRT 
(66 pts) were secured their whole body using MOLDCARE RI II 
(ALCARE). We measured the travel distance of the center of 
gravity of the three gold markers in the prostate gland using 
the real-time tumor tracking system. We defined the travel 
distance of the first half (the early phase) and latter half (the 
later phase) of the intra-fraction prostate motion errors right 
after the initiation of irradiation. In addition, we analyzed 
the differences caused by the fixation methods (fixture). 
 
Results: A total of 9,750 times of irradiation (3DCRT：4,732; 
IMRT：5,018) were analyzed in this study. The overall 
duration of daily irradiation was 13.83±2.24 minutes. The 
travel distance of the prostate was 1.50±1.13 mm in the 
entire one time irradiation, 1.75±1.21 mm in the early phase, 
and 1.24±0.98 mm in the later phase. The statistical analysis 
using the Bonferroni method showed a significant difference 
between the both phases (p<0.001). The intra-fractional 
prostate motion errors in the early phase were 1.96±1.36 mm 
by 3DCRT and 1.55±1.01 mm by IMRT. A significant difference 
was observed in the intra-fractional prostate motion errors in 
the early phase between two fixation methods. In contrast, 
the intra-fraction prostate motion errors in the later phase 
were almost equal regardless of the fixation methods. 
 
Conclusion: The temporal movement of the prostate during 
daily irradiation becomes larger in the early phase of 
irradiation, and this result is influenced by the set-up 
methods and the patient fixing devices. Since the dose 
gradient is steep in 3DCRT and IMRT, even a minimal 
movement of the prostate associated with the intra-fraction 
prostate motion errors is likely to cause a fatal irradiation 
error of a high dose rate machine. Therefore, the movement 
of the prostate in the early phase would require careful 
attention in the treatment of prostate cancer patients. 
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Purpose or Objective: The purpose of this study is to 
quantitatively estimate gamma (γ) passing rates from 
characteristics of respiratory motion. 
 
Material and Methods: A VMAT plan for lung cancer patients, 
which was designed using Pinnacle3 (ver. 9.2; Philips Ltd, 
USA), was used. Measurements were performed on the Elekta 
Synergy (Elekta Oncology Systems Ltd, Crawley, UK), which 
has a 160-leaf independently moving MLC with 5-mm leaf 
width. Beam energy was set to 6 MV photon beam. The I’mRT 
Phantom (IBA Dosimetry GmbH, Schwarzenbruck, Germany) 
was set on a motor-driven base (QUASAR Programmable 
Respiratory Motion Platform; Modus Medical, London, ON, 
Canada). The motor-driven base moved in a direction parallel 
to the couch direction at angle of 0 deg. A total of 148 
respiratory patterns was tested. The doses delivered to the 
Gafchromic EBT3 films (Kodak, Rochester, NY), inserted in 
the coronal plane of the I’mRT Phantom, were compared 
with under moving and static conditions without dose 
normalization. The irradiated films were scanned in the same 
orientation using a resolution of 72 dpi in the 16-bit red-
channel color scale. Four pinholes were made on each film to 
identify the irradiated center. All of the films were analyzed 
using commercially available radiation dosimetry software 
(DD system, ver. 10.4; R’Tech Inc., Tokyo, Japan). The 
passing rates of the γ with the criterion of 3%/3 mm 
(γ3%/3mm) were calculated in the area receiving more than 
30% of the isodose. In addition, mean respiratory position (μ) 
and its standard deviations (σ) were calculated from 
respiratory curves during beam irradiation. 
 
Results: Absolute value of μ (|μ|) and σ ranged from 0.0 to 
8.5 mm, and from 1.5 to 6.7 mm, respectively. Multi-
regression analysis revealed that the impact of σ on the 
γ3%/3mm had 0.66-fold greater than that of |μ|. Means±SDs 
of the γ3%/3mm and the |μ|+0.66σ (|μ|+0.66σ) were 
83.1±14.0% (range, 38.7-100.0%), and 8.7±3.1 mm (range, 
4.6-14.2 mm), respectively. A strong correlation between the 
γ3%/3mm and |μ|+0.66σ was observed (R=-0.90).  
 
